E-LIB Suche - Ergebnisse für: Akkoç, Nihan

1

Clinical Outcomes Related to the Use of Bendamustine Therap..:

Yalnız, Fevzi Fırat ; Akkoç, Nihan ; Salihoğlu, Ayşe...
Turkish Journal of Hematology. , 2017

Link: https://doi.org/10.4274/..

2

Survival outcomes of patients with HER2/neu‐positive breast..:

Akkoc Mustafayev, Fatma Nihan ; Shukla, Mihir Amitabh ; Lanier, Amanda...
Cancer. 130 (2023) 9 - p. 1600-1608 , 2023

Link: https://doi.org/10.1002/..

3

The percentage of ALK-positive cells and the efficacy of fi..:

Hizal, Mutlu ; Bilgin, Burak ; Paksoy, Nail...
Journal of Cancer Research and Clinical Oncology. 149 (2022) 8 - p. 4141-4148 , 2022

Link: https://doi.org/10.1007/..

4

Immunogenicity of Infliximab Among Patients With Behçet Syn..:

Esatoglu, Sinem Nihal ; Akkoc-Mustafayev, Fatma Nihan ; Ozguler, Yesim...
Frontiers in Immunology. 11 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

5

Clinical Outcomes Related to the Use of Bendamustine Therap..:

Fevzi Fırat Yalnız ; Nihan Akkoç ; Ayşe Salihoğlu...
https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-56659. , 2017

Link: https://doi.org/10.4274/..

6

Immunological effects of human decidual mesenchymal stem ce..:

Büyükbayrak, Esra Esim ; Gündoğdu, Nur Ecem Öztop ; Gürkan, Nihan...
Journal of Reproductive Immunology. 162 (2024) - p. 104193 , 2024

Link: https://doi.org/10.1016/..

7

Short-Term Biomarker Modulation Study of Dasatinib for Estr..:

Fatma Nihan Akkoc Mustafayev ; Diane D. Liu ; Angelica M. Gutierrez...
http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/short-term-biomarker-modulation-study-of-dasatinib/62264. , 2023

Link: https://doi.org/10.4274/..

8

Decrease in estimated glomerular filtration rates in non-sm..:

İriagaç, Yakup ; Çavdar, Eyyüp ; Karaboyun, Kubilay...
Journal of cancer research and therapeutics. , 2023

Link: https://doi.org/10.4103/..

9

Short-Term Biomarker Modulation Study of Dasatinib for Estr..:

Akkoc Mustafayev, Fatma Nihan ; Liu, Diane D ; Gutierrez, Angelica M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546803/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Immunogenicity of Infliximab Among Patients With Behçet Syn..:

Sinem Nihal Esatoglu ; Fatma Nihan Akkoc-Mustafayev ; Yesim Ozguler...
https://www.frontiersin.org/articles/10.3389/fimmu.2020.618973/full. , 2020

Link: https://doi.org/10.3389/..

11

Decrease in estimated glomerular filtration rates in non-sm..:

Iriagac, Yakup ; Cavdar, Eyyup ; Karaboyun, Kubilay...
Journal of Cancer Research and Therapeutics. , 2023

Link: https://doi.org/10.4103/..

12

The percentage of ALK-positive cells and the efficacy of fi..:

Aydiner, Adnan ; Ayhan, Murat ; KESKİNKILIÇ, MERVE...
c660c78b-2ee2-43de-ab96-b732abd5a4c2. , 2023

Link: https://doi.org/10.1007/..

13

Prognostic value of expression levels of miR-148a, miR-152 ..:

Emirzeoglu, Levent ; Olmez, Ozgur ; Mustafayev, Fatma Nihan Akkoc...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185158/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Immunogenicity of Infliximab Among Patients With Behçet Syn..:

Esatoglu, Sinem Nihal ; Akkoc-Mustafayev, Fatma Nihan ; Ozguler, Yesim...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782473/. , 2020

Link: http://www.ncbi.nlm.nih...

15

Immunogenicity of Infliximab Among Patients With Behcet Syn..:

Esatoglu, Sinem Nihal ; Akkoc-Mustafayev, Fatma Nihan ; Ozguler, Yesim...
Frontiers In Immunology. , 2020

Link: https://doi.org/10.3389/..